Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (481-490 of 1,253) with videos related to

Pageof 126
Sort By:
American Journal of Epidemiology|March 7, 2015
Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External ExpertsVéronique L Roger, Eric Boerwinkle, James D Crapo, et al.
Journal of the American Geriatrics Society|December 20, 2022
Lipid-lowering treatment among older patients with atherosclerotic cardiovascular diseaseMichael G Nanna, Adam J Nelson, Kevin Haynes, et al.
European Journal of Heart Failure|September 6, 2017
Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortalityElke Platz, Pardeep S Jhund, Brian L Claggett, et al.
JAMA|April 14, 2005
Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomesRajendra H Mehta, John H Alexander, Frans Van de Werf, et al.
European Heart Journal|October 11, 2005
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary interventionPeter R Sinnaeve, John Simes, Salim Yusuf, et al.
Pharmaceutical Medicine|August 31, 2025
Embedding Implementation Science in Clinical Trials: A Framework for Academic-Life Science PartnershipsTyler L Cope, Emily C O'Brien, Neha J Pagidipati, et al.
American Heart Journal|April 8, 2003
Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudyVictor L Serebruany, Alex I Malinin, Kevin P Callahan, et al.
Nano Letters|January 25, 2018
Control of Energy Flow Dynamics between Tetracene Ligands and PbS Quantum Dots by Size Tuning and Ligand CoverageDaniel M Kroupa, Dylan H Arias, Jeffrey L Blackburn, et al.
Stroke|September 10, 1998
Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trialJ M Gebel, C A Sila, M A Sloan, et al.
International Journal of Cardiology|February 21, 2015
Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery diseaseMiklos Rohla, Christoph Kleine Vennekate, Ioannis Tentzeris, et al.
Pageof 126

Showing results (481-490 of 1,253) with videos related to

Sort By:
Pageof 126
American Journal of Epidemiology|March 7, 2015
Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External ExpertsVéronique L Roger, Eric Boerwinkle, James D Crapo, et al.
Journal of the American Geriatrics Society|December 20, 2022
Lipid-lowering treatment among older patients with atherosclerotic cardiovascular diseaseMichael G Nanna, Adam J Nelson, Kevin Haynes, et al.
European Journal of Heart Failure|September 6, 2017
Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortalityElke Platz, Pardeep S Jhund, Brian L Claggett, et al.
JAMA|April 14, 2005
Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomesRajendra H Mehta, John H Alexander, Frans Van de Werf, et al.
European Heart Journal|October 11, 2005
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary interventionPeter R Sinnaeve, John Simes, Salim Yusuf, et al.
Pharmaceutical Medicine|August 31, 2025
Embedding Implementation Science in Clinical Trials: A Framework for Academic-Life Science PartnershipsTyler L Cope, Emily C O'Brien, Neha J Pagidipati, et al.
American Heart Journal|April 8, 2003
Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudyVictor L Serebruany, Alex I Malinin, Kevin P Callahan, et al.
Nano Letters|January 25, 2018
Control of Energy Flow Dynamics between Tetracene Ligands and PbS Quantum Dots by Size Tuning and Ligand CoverageDaniel M Kroupa, Dylan H Arias, Jeffrey L Blackburn, et al.
Stroke|September 10, 1998
Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trialJ M Gebel, C A Sila, M A Sloan, et al.
International Journal of Cardiology|February 21, 2015
Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery diseaseMiklos Rohla, Christoph Kleine Vennekate, Ioannis Tentzeris, et al.
Pageof 126